Clinical trial begins province of Cuba on drug for Alzheimer's
  • last year
The phase III clinical trial to evaluate the efficacy and safety of the neuroprotective NeuralCIM in patients with mild or moderate amnestic variant Alzheimer's is being developed in this central province of Cuba, health specialists report on Monday. teleSUR